Farnesyltransferase Inhibitors in Cancer Therapy

Lydia Armstrong, phd: Schering-Plough Research Institute, Kenilworth, NJ Lorena S. Beese, phd: Department of Biochemistry, Duke University Medical Center, Durham NC Eric J. Bernhard, phd: Department of Radiation Oncology, University of Pennsylvania Medical Center, Philadelphia W. Robert Bishop, phd: Schering-Plough Research Institute, Kenilworth, NJ Marie-Christine Bissery, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Jean-Dominique Bourzat, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Clive Brealey, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Frederick S. Buckner, phd: Department of Medicine, University of Washington, Seattle Marc Capet, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Patrick J. Casey, phd: Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC Michel Cheve, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Elizabeth Cohen-Jonathan, md, phd: Department of Radiation Oncology, University of Pennsylvania Medical Center, Philadelphia Alain Commercon, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Adrienne D. Cox, phd: Departments of Radiation Oncology, Pharmacology, and Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill Marguerite B. Dalton, phd: Department of Biochemistry and Molecular Biology, East Tennessee State University, Johnson City Keith Del Villar, phd: Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles Channing J. Der, phd: Department of Pharmacology and Curriculum in Genetics and Molecular Biology, Curriculum in Toxicology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill Norbert Dereu, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Ronald J. Doll, phd: Schering-Plough Research Institute, Kenilworth, NJ Marc Duchesne, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Craig Fairchild, phd: Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ Gilles Favre, phd: Centre Claudius Regaud, Toulouse, France Carol A. Fierke, phd: Department of Biochemistry, Duke University Medical Center, Durham, NC James J. Fiordalisi, phd: Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill Michael H. Gelb, phd: Departments of Chemistry and Biochemistry, University of Washington, Seattle Jackson B. Gibbs, phd: Department of Cancer Research, Merck Research Laboratories, West Point, PA Samuel L. Graham, phd: Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA Jean-Dominique Guitton, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Andrew D. Hamilton, phd: Department of Chemistry, Yale University, New Haven, CT George D. Hartman, phd: Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA Chih-Chin Huang, phd: Department of Biochemistry, Duke University Medical Center, Durham NC Gary R. Hudes, md: Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA MeeRhan Kim, phd: Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles Paul Kirschmeier, phd: Schering-Plough Research Institute, Kenilworth, NJ Kenneth S. Koblan, phd: Department of Cancer Research, Merck Research Laboratories, West Point, PA Nancy E. Kohl, phd: Department of Cancer Research, Merck Research Laboratories, West Point, PA David Knowles, phd: Department of Chemistry, University of Pittsburgh, PA Abdel Laoui, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Jacques Lavayre, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Francois Lavelle, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Alain LeBrun, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Frank Lee, phd: Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ Yves Lelievre, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Daniele M. Leonard, phd: Department of Chemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, MI W. R. Leopold, phd: Department of Cancer Research, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, MI Ming Liu, phd: Schering-Plough Research Institute, Kenilworth, NJ Stephen B. Long, phd: Department of Biochemistry, Duke University Medical Center, Durham, NC Patrick Mailliet, md: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Veeraswamy Manne, phd: Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ Jean-Paul Martin, MD: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France W. Gillies McKenna, md, phd: Department of Radiation Oncology, University of Pennsylvania Medical Center, Philadelphia, PA Ruth J. Muschel, md, phd: Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, PA Lisa Nguyen, phd: Department of Medicine, University of Washington, Seattle, WA George Njoroge, phd: Schering-Plough Research Institute, Kenilworth, NJ Junko Ohkanda, phd: Department of Chemistry, Yale University, New Haven, CT Allen Oliff, md: Department of Cancer Research, Merck Research Laboratories, West Point, PA Charles Omer, phd: Department of Cancer Research, Merck Research Laboratories, West Point, PA James J.-K. Pai, phd: Schering-Plough Research Institute, Kenilworth, NJ Guy Pantel, md: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Amita Patnaik, md: Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX Angel Pellicier, md, phd: Department of Pathology and Kaplan Cancer Center, NYU Medical Center, New York Jean-Francois Peyronel, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France George C. Prendergast, phd: Dupont Pharmaceuticals, Glenolden, PA Jean-Francois Riou, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Nicole Robinson, phd: Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles Kelley Rogers-Graham, bs: Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill William C. Rose, phd: Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ Saul Rosenberg, phd: Department of Cancer Research, Abbott Laboratories, Abbott Park, IL Bartira Rossi-Bergmann, phd: Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil Eric K. Rowinsky, md: Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX Christophe Salagnad, md: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Jessie Schol, rn: Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA Judith S. Sebolt-Leopold, phd: Department of Cell Biology, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, MI Said M. Sebti, phd: Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa Michael Sinensky, phd: Department of Biochemistry and Molecular Biology, East Tennessee State University, Johnson City Kenneth D. Stuart, phd: Department of Pathobiology, University of Washington, Seattle, WA; and Seattle Biomedical Research Institute, Seattle Jiahzi Sun, phd: Drug Discovery Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa Fuyuhiko Tamanoi, phd: Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles Arthur Taveras, phd: Schering-Plough Research Institute, Kenilworth, NJ Fabienne Thompson, md: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France L. Gerard Toussaint III, md: Departments of Radiation Oncology and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill Jun Urano, phd: Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles Wesley C. Van Voorhis, phd: Department of Medicine, University of Washington, Seattle Patricia Vrignaud, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, France Jolene Windle, phd: Cancer Therapy and Research Center, San Antonio, TX Paul Workman, phd: CRC Center for Cancer Therapeutics at the Institute for Cancer Research, Surrey, UK Ning Yan, phd: Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ Wenli Yang, phd: Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles Kohei Yokoyama, phd: Departments of Chemistry and Biochemistry, University of Washington, Seattle Fang Zhang, phd: Schering-Plough Research Institute, Kenilworth, NJ Martine Zucco, phd: Rhone-Poulenc-Rorer S.A., Vitry sur Seine, FranceSebti, Said M. is the author of 'Farnesyltransferase Inhibitors in Cancer Therapy' with ISBN 9780896036291 and ISBN 0896036294.